1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Neoantigens Market – By Treatment
1.3.2 North America Neoantigens Market – By Therapeutic Specialty
1.3.3 North America Neoantigens Market– By Country
2. North America Neoantigens Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Neoantigens Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Expert Opinion
5. North America Neoantigens Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Developments in Neoantigen Vaccines Against Cancer
5.1.2 Increasing Prevalence of Cancer
5.2 Market Restraints
5.2.1 Possible Side Effects Associated with Neoantigen Vaccines
5.3 Market Opportunities
5.3.1 Application of Next-generation Sequencing for Neoantigen Identification
5.4 Future Trends
5.4.1 Use of AI in Neoantigen Vaccine Development
5.5 Impact Analysis
6. Neoantigens Market – North America Analysis
6.1 North America Neoantigens Market Revenue Forecast and Analysis
7. North America Neoantigens Market Analysis – By Treatment
7.1 Overview
7.2 North America Neoantigens Market Revenue Share, by Treatment (2023 and 2028)
7.3 Combination Therapy
7.3.1 Overview
7.3.2 Combination Therapy: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
7.4 Mono Therapy
7.4.1 Overview
7.4.2 Mono Therapy: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
8. North America Neoantigens Market Analysis – By Therapeutic Specialty
8.1 Overview
8.2 North America Neoantigens Market Revenue Share, by Therapeutic Specialty (2023 and 2028)
8.3 Gastrointestinal Cancer
8.3.1 Overview
8.3.2 Gastrointestinal Cancer: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
8.4 Lung Cancer
8.4.1 Overview
8.4.2 Lung Cancer: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
8.5 Solid Tumors
8.5.1 Overview
8.5.2 Solid Tumors: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
8.6 Urinary System Cancers
8.6.1 Overview
8.6.2 Urinary System Cancers: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
8.7 Melanoma
8.7.1 Overview
8.7.2 Melanoma: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
8.8 Head and Neck Cancers
8.8.1 Overview
8.8.2 Head and Neck Cancers: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
8.9 Others
8.9.1 Overview
8.9.2 Others: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
9. North America Neoantigens Market – Country Analysis
9.1 North America: Neoantigens Market Revenue and Forecast to 2028
9.1.1 Overview
9.1.2 North America: Neoantigens Market, by Country, 2023 & 2028 (%)
9.1.3 US: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.3.1 US: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.3.2 US: Neoantigens Market, by Treatment, 2023–2028 (USD Thousand)
9.1.3.3 US: Neoantigens Market, by Therapeutic Specialty, 2023–2028 (USD Thousand)
9.1.4 Canada: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.4.1 Canada: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.4.2 Canada: Neoantigens Market, by Treatment, 2023–2028 (USD Thousand)
9.1.4.3 Canada: Neoantigens Market, by Therapeutic Specialty, 2023–2028 (USD Thousand)
9.1.5 Mexico: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.5.1 Mexico: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
9.1.5.2 Mexico: Neoantigens Market, by Treatment, 2023–2028 (USD Thousand)
9.1.5.3 Mexico: Neoantigens Market, by Therapeutic Specialty, 2023–2028 (USD Thousand)
10. Impact Of COVID-19 Pandemic on North America Neoantigens Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. North America Neoantigens Market–Industry Landscape
12. Company Profiles
12.1 Advaxis, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Gradalis, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Gritstone Oncology
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medigene AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ziopharm Oncology, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Moderna, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. New Cancer Cases Registered Worldwide, 2020
Table 2. North America Neoantigens Market – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Neoantigens Market, by Treatment – Revenue and Forecast to 2028 (USD Thousand)
Table 4. US: Neoantigens Market, by Therapeutic Specialty – Revenue and Forecast to 2028 (USD Thousand)
Table 5. Canada: Neoantigens Market, by Treatment – Revenue and Forecast to 2028 (USD Thousand)
Table 6. Canada: Neoantigens Market, by Therapeutic Specialty – Revenue and Forecast to 2028 (USD Thousand)
Table 7. Mexico: Neoantigens Market, by Treatment – Revenue and Forecast to 2028 (USD Thousand)
Table 8. Mexico: Neoantigens Market, by Therapeutic Specialty – Revenue and Forecast to 2028 (USD Thousand)
Table 9. Market Developments Done By Companies
Table 10. Glossary of Terms, Neoantigens Market
LIST OF FIGURES
Figure 1. North America Neoantigens Market Segmentation
Figure 2. North America Neoantigens Segmentation, By Country
Figure 3. North America Neoantigens Market Overview
Figure 4. Combination Therapy Segment Holds Largest Share of North America Neoantigens Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Expert Opinion
Figure 8. North America Neoantigens Market Impact Analysis of Drivers and Restraints
Figure 9. North America Neoantigens Market – Revenue Forecast and Analysis – 2023- 2028
Figure 10. North America Neoantigens Market Revenue Share, by Treatment (2023 and 2028)
Figure 11. Combination Therapy: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 12. Mono Therapy: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 13. North America Neoantigens Market Revenue Share, by Therapeutic Specialty (2023 and 2028)
Figure 14. Gastrointestinal Cancer: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 15. Lung Cancer: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 16. Solid Tumors: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 17. Urinary System Cancers: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 18. Melanoma: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 19. Head and Neck Cancers: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 20. Others: North America Neoantigens Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 21. North America: Neoantigens Market, by Key Country – Revenue (2023) (USD Thousand)
Figure 22. North America: Neoantigens Market, by Country, 2023 & 2028 (%)
Figure 23. US: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 24. Canada: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 25. Mexico: Neoantigens Market – Revenue and Forecast to 2028 (USD Thousand)
Figure 26. Impact of COVID-19 Pandemic in North American Country Markets
